You have 1 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Molecular subtypes

Showing 26 - 50 of 5,891
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Breast Tumors, Breast Cancer Female Trial in Istanbul (Axillary sentinal lymph node biopsy)

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Axillary sentinal lymph node biopsy
  • İstanbul, Bagcilar, Turkey
  • +1 more
Oct 22, 2023

Pancreatic Cancer Molecular Sub-classification Using Endoscopic

Active, not recruiting
  • Pancreas Cancer
    • Rome, Italy
      Universita' Cattolica del Sacro Cuore
    Feb 10, 2022

    Lung Cancer ID (Identity) Study

    Not yet recruiting
    • Lung Cancer Stage IV
    • Advanced lung cancer patients' group
    • Roma, Italy
    • +1 more
    Oct 4, 2023

    Multimodal Image Recognition System of Glioma Based on Deep

    Not yet recruiting
    • Glioma
    • PET/CT, H-MRS and MRI
    • (no location specified)
    Sep 7, 2021

    VIPER: Veterans Integrated Pain Evaluation Research

    Completed
    • Pain
      • Bethesda, Maryland
        Walter Reed National Military Medical Center
      Aug 13, 2019

      Colorectal Cancer Peritoneal Metastases

      Not yet recruiting
      • Colorectal Cancer Metastatic
      • Retrospective tissue sample analysis
      • (no location specified)
      Aug 22, 2022

      TNBC - Triple-Negative Breast Cancer Trial (A1:SG with SHR3680, A2:SG, B1:SG with SHR1210)

      Not yet recruiting
      • TNBC - Triple-Negative Breast Cancer
      • A1:SG with SHR3680
      • +7 more
      • (no location specified)
      Jun 23, 2023

      Pancreatitis, Acute Trial in Hvidovre (LiDCO)

      Recruiting
      • Pancreatitis, Acute
      • LiDCO
      • Hvidovre, Capital, Denmark
        Gastroenheden, Hvidovre Hospital
      Aug 1, 2022

      Molecular Classification of Relapsed/Refractory Diffuse Large

      Completed
      • Lymphoma, Large B-Cell, Diffuse
      • Gene Expression Profiling
      • Gene expression profile
      • Shanghai, Shanghai, China
        Yian Zhang
      Mar 31, 2022

      (CMS), UGT1A1 Genotype and Beta-glucuronidase Activity of

      Recruiting
      • Colorectal Neoplasms
        • Maastricht, Limburg, Netherlands
          Maastricht UMC+
        Jan 10, 2023

        Molecular Pathology Research Project of Glioma

        Completed
        • Glioma, Malignant
        • Detection of IDH and TERT mutation
        • Shanghai, Jingan District, China
          Huashan Hospital
        Mar 9, 2022

        Breast Cancer Female, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial in Kampala

        Completed
        • Breast Cancer Female
        • +11 more
        • Kampala, Uganda
        • +1 more
        Jun 7, 2022

        Kidney Tumors Trial in Taoyuan (multiparametric and fat-detection magnetic resonance imaging (MRI))

        Active, not recruiting
        • Kidney Neoplasms
        • multiparametric and fat-detection magnetic resonance imaging (MRI)
        • Taoyuan, Taiwan
          Li-Jen Wang
        Nov 9, 2023

        Spatial Location of Breast Cancer Local Recurrence After

        Active, not recruiting
        • Breast Cancer
        • Mastectomy
        • Maastricht, Limburg, Netherlands
          Maastro
        Nov 7, 2023

        ArTificial inTelligence-based RAdiogenomics in Colon Tumors

        Recruiting
        • Colon Cancer Stage II
        • Colon Cancer Stage III
          • Roma, RM, Italy
            AOU Sant'Andrea
          Oct 24, 2023

          Glioma Trial (Blood sampling)

          Not yet recruiting
          • Glioma
          • Blood sampling
          • (no location specified)
          Oct 31, 2023

          Blastocystis Isolates From Human by Restriction Fragment Length

          Not yet recruiting
          • Blastocystis Infections
          • RFLP analysis of SSU rRNA
          • (no location specified)
          Oct 13, 2022

          Neuroendocrine Neoplasm Based on Multi-omics Integrated Analysis

          Not yet recruiting
          • Neuroendocrine Neoplasm
          • Biopsy/surgical tissue and peripheral blood
          • Shanghai, Shanghai, China
            Department of Pancreatic Surgery, Fudan University Shanghai Canc
          Jun 12, 2021

          NSCLC Trial in Italy (Atezolizumab)

          Recruiting
          • Non-Small Cell Lung Cancer
          • Orbassano, Torino, Italy
          • +11 more
          Dec 21, 2020

          Molecular Characterisation of Appendiceal Cancer

          Not yet recruiting
          • Appendiceal Cancer
          • Retrospective tissue sample analysis
          • (no location specified)
          Aug 22, 2022

          Molecular Mechanism Study of Uterine Sarcoma

          Recruiting
          • Uterine Sarcoma
          • Diagnostic biomarker
          • Wuhan, Hubei, China
            Yan Li
          May 21, 2023

          Depressive Disorder, Major, Treatment Outcome, Cognitive Dysfunction Trial in Copenhagen (Treatment Package for First-Episode

          Recruiting
          • Depressive Disorder, Major
          • +4 more
          • Treatment Package for First-Episode Depression
          • Copenhagen, Denmark
            Neurobiology Research Unit, Rigshospitalet
          Nov 12, 2022

          Tendinopathy Trial in Hangzhou (platelet rich plasma, Corticosteroid, Normal saline)

          Recruiting
          • Tendinopathy
          • platelet rich plasma
          • +2 more
          • Hangzhou, Zhejiang, China
            2nd Affiliated Hospital, School of Medicine, Zhejiang University
          Oct 28, 2022

          New Treatment Strategies in Eastern European Region and in

          Recruiting
          • HIV-1-infection
            • Cologne, Germany
            • +3 more
            Nov 10, 2023

            Mild Cognitive Impairment(MCI), Alzheimer, Late Onset, Familial Alzheimer (FAD) Trial in China

            Recruiting
            • Mild Cognitive Impairment(MCI)
            • +5 more
              • Hefei, Anhui, China
              • +64 more
              Jan 2, 2023